Skip to main content
FinSpry Logo
FinSpry
TRAX logo
TRAX
(NASDAQ)
First Tracks Biotherapeutics, Inc.
$37.64-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

First Tracks Biotherapeutics (TRAX) Stock Price & Financial Analysis

First Tracks Biotherapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$36.44 - $38.96
52-Week High$42.90
52-Week Low$14.72
Open$37.75
Volume380.27K
Average Volume (3M)843.86K
Market Cap1.31B
Shares Outstanding34.75M
Price to Book (P/B)5.08
EV/EBITDA-5.94
50-Day MA$21.53
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About First Tracks Biotherapeutics

What is the current stock price for TRAX?

As of the latest trading session, TRAX stock trades at $37.64. The 52-week range is $14.72–$42.90, with a day range of $36.44–$38.96.

What is the P/E ratio for TRAX?

The P/E ratio (Price-to-Earnings) for TRAX is shown in the Key Statistics section. This valuation metric helps compare First Tracks Biotherapeutics, Inc. to industry peers.

Does TRAX pay dividends?

First Tracks Biotherapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TRAX?

Based on 7 analysts, the consensus for TRAX is Buy.

What is the market cap of TRAX?

First Tracks Biotherapeutics's market capitalization is $1.31B, classifying it as a small-cap company. First Tracks Biotherapeutics operates in the Healthcare sector within the Biotechnology industry.